1-minute read
written by
Petr Kašík
tags
In November 2023, DIANA Biotechnologies participated in MEDICA Trade Fair 2023, the largest international healthcare event in Europe, held in Düsseldorf, Germany. The prestigious fair, which was accompanied by a series of smaller conferences, workshops and panel discussions, attracted a total of 83,000 people from all over the world.
For DIANA Biotechnologies, participation at MEDICA represented a significant milestone in its business and marketing development, as well as a key step in building its reputation on the international stage. The company was present at the fair with a broad portfolio that included the latest PCR products for research laboratories and diagnostics, especially its unique DBdirect and SuperSens technologies, which allow users to reduce the cost and time required to obtain accurate results.
During the event, DIANA Biotechnologies' sales team established new contacts with international suppliers, distributors and end-users, expanding its network of business partners while strengthening existing partnerships. Thus, DIANA Biotechnologies' participation at MEDICA 2023 opened up new opportunities for growth and development in the biotechnology industry.
Media contact:
Petr Kašík+420734513384
E-mail: [email protected]
Tel: +420734513384
About DIANA Biotechnologies
DIANA Biotechnologies, a.s. is a Czech biotechnology company with strong in-house research and development. The company was founded in 2018 with the aim to develop applications of the patented DIANA technology in diagnostics and drug development. However, the company's portfolio is now significantly broader. It is currently targeting global markets in three main areas: 1) development and production of PCR products for diagnostics and life science, 2) development of proprietary original low molecular weight drugs and provision of services to the pharmaceutical sector, and 3) development of antibodies for diagnostics and therapeutics. In the field of molecular diagnostics, the company has become the largest Czech manufacturer of PCR tests for COVID-19 and other viral diseases and is now making its mark abroad thanks to its innovations in PCR diagnostics. The company is built on a team of top scientists with unique expertise in molecular biology, biochemistry, organic and medicinal chemistry, pharmacology and laboratory automation. DIANA Biotechnologies aims to become a multinational biotechnology company developing its own original diagnostics and pharmaceuticals. For more information about the company, please continue to www.dianabiotech.com
The Czexpats in Science initiative brings together a community of more than a thousand Czech scientists who work or have worked abroad. The organization's mission is to connect Czech scientists with past, present and future international experience and together inspire and positively influence the Czech scientific environment to make Czech science as open, global and ambitious as possible. The association fulfils this mission by organising networking events in the Czech Republic and abroad, by the project of the unique interactive Map of Scientists, by educational activities, by raising the profile of the achievements of Czech scientists abroad and by advocating for systemic changes in Czech science policy. More at www.czexpats.org